TRPC4
MOLECULAR TARGETtransient receptor potential cation channel, subfamily C, member 4
TRPC4 (transient receptor potential cation channel, subfamily C, member 4) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TRPC4
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | m084 | 1.95 | 6 |
| 2 | Hexachlorophene | 1.39 | 3 |
| 3 | Methylene Blue | 1.10 | 2 |
| 4 | Amoxapine | 1.10 | 2 |
| 5 | Fluspirilene | 1.10 | 2 |
| 6 | Promethazine | 1.10 | 2 |
| 7 | propionylpromazine hydrochloride | 1.10 | 2 |
| 8 | triflupromazine hydrochloride | 1.10 | 2 |
| 9 | 2-Chloroadenosine 2-Chloroadenosine. | 0.69 | 1 |
| 10 | Calcimycin | 0.69 | 1 |
| 11 | Carvedilol | 0.69 | 1 |
| 12 | Guanfacine | 0.69 | 1 |
| 13 | Niflumic Acid | 0.69 | 1 |
| 14 | Promazine | 0.69 | 1 |
| 15 | Thioridazine | 0.69 | 1 |
About TRPC4 as a Drug Target
TRPC4 (transient receptor potential cation channel, subfamily C, member 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented TRPC4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TRPC4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.